Detalhe da pesquisa
1.
Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis.
Lancet Oncol
; 19(3): 310-322, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29449192
2.
Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial.
Lancet
; 386(9992): 444-51, 2015 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26037941
3.
Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial.
Lancet Oncol
; 16(13): 1389-98, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26433819
4.
Remote Monitoring and Data Collection for Decentralized Clinical Trials.
JAMA Netw Open
; 7(4): e246228, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38607626
5.
Inhibition of phosphodiesterase type 4 decreases stress-induced defecation in rats and mice.
Pharmacology
; 81(1): 11-7, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-17726343
6.
Three-year pooled analysis of factors associated with clinical outcomes across dabrafenib and trametinib combination therapy phase 3 randomised trials.
Eur J Cancer
; 82: 45-55, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28648698
7.
Non-surgical management of spinal cord injury.
Expert Opin Investig Drugs
; 11(4): 469-82, 2002 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-11922856
8.
Pharmacological interventions for stroke: failures and future.
Expert Opin Investig Drugs
; 11(5): 603-14, 2002 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-11996643
9.
Update on pharmacological strategies for stroke: prevention, acute intervention and regeneration.
Curr Opin Investig Drugs
; 4(7): 847-58, 2003 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-14619407
10.
Programmable microchip monitoring of post-stroke pyrexia: effects of aspirin and paracetamol on temperature and infarct size in the rat.
J Neurosci Methods
; 113(2): 159-66, 2002 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-11772437
11.
The selective p38 inhibitor SB-239063 protects primary neurons from mild to moderate excitotoxic injury.
Eur J Pharmacol
; 447(1): 37-42, 2002 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-12106800
12.
Selective CETP inhibition and PPARalpha agonism increase HDL cholesterol and reduce LDL cholesterol in human ApoB100/human CETP transgenic mice.
J Cardiovasc Pharmacol Ther
; 15(2): 196-202, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20332533
13.
SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
Exp Neurol
; 212(1): 53-62, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18462720
14.
Selective PPARdelta agonist treatment increases skeletal muscle lipid metabolism without altering mitochondrial energy coupling: an in vivo magnetic resonance spectroscopy study.
Am J Physiol Endocrinol Metab
; 293(5): E1256-64, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17726146
15.
LEX032, a novel recombinant serpin, protects the brain after transient focal ischemia.
Microvasc Res
; 63(3): 327-34, 2002 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-11969309
16.
Caspase 3 activation is essential for neuroprotection in preconditioning.
Proc Natl Acad Sci U S A
; 100(2): 715-20, 2003 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-12522260
17.
Nonpeptide tachykinin receptor antagonists. III. SB 235375, a low central nervous system-penetrant, potent and selective neurokinin-3 receptor antagonist, inhibits citric acid-induced cough and airways hyper-reactivity in guinea pigs.
J Pharmacol Exp Ther
; 300(1): 314-23, 2002 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-11752131